Mobile

A research study to evaluate the effect of 3 different doses of a new medicine (glycopyrrolate) administered in combination with a licenced medicine (Foster®) in patients with uncontrolled asthma

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-003043-36

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy of a free combination of CHF 5259 (glycopyrrolate bromide [GB]) at 3 dose levels plus Foster 100/6 µg (fixed combination of beclomethasone dipropionate [BDP] plus formoterol [FF]) in a metered dose inhaler by comparison with Foster 100/6 µg in terms of FEV1 AUC0-12h normalised by time on Day 42.

Critère d'inclusion

  • uncontrolled asthma

Liens